Founded in 2014, ARTPred B.V. is a research driven medtech company in the field of IVF. It is our vision is to fundamentally change infertility care worldwide. The mission of ARTPred is to make its unique technology available for all IVF patients. ARTPred has, together with our partners, developed, world’s first validated fertility microbiome profiling test. ReceptIVFity is CE-IVD certified and sold in the E.U. ARTPred is performing new clinical trials to further strengthen our predictive test in other geographical regions and to develop therapeutic interventions that improve the female microbiome and fertility outcome.
Looking for a particular ARTPred employee's phone or email?
ARTPred Questions
The ARTPred annual revenue was $4 million in 2026.
Jonathan de Jonge is the Co-Founder, Chief Operations Officer and Business Development of ARTPred.
1 people are employed at ARTPred.
ARTPred is based in Hoofddorp, North Holland.
The NAICS codes for ARTPred are [54171, 54, 5417, 541, 541713].
The SIC codes for ARTPred are [87, 873].
Top ARTPred Employees
Related Companies
